Nureca Ltd (NURECA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 1003462, "name": "Nureca", "stock_name": "Nureca", "full_name": "Nureca Ltd", "name_url": "stocks-analysis/nureca", "exchange": 0, "exchangecode": "", "country_id": 34, "currency": "INR", "cmp": "282.75", "chg": -2.05, "chgp": "-0.72%", "dir": -1, "prev_price": "284.80", "mcapval": "277.00 Cr", "mcap": "Micro Cap", "scripcode": 543264, "symbol": "NURECA", "ind_name": "Healthcare Services", "ind_code": 26, "indexname": "", "isin": "INE0DSF01015", "curr_date": "Jan 29", "curr_time": "", "bse_nse_vol": "22.0 k", "exc_status": "Active", "traded_date": "Jan 29, 2026", "traded_date_str": "2026 01 29", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/nureca-1003462-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Nureca Ltd Falls 9.26%: 3 Key Factors Driving the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-falls-926-3-key-factors-driving-the-weekly-decline-3803208", "imagepath": "", "date": "2026-01-24 11:05:02", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Jan 19:</strong> Stock surged to upper circuit at ₹322.05 (+5.0%)</p>\n <p><strong>Jan 20:</strong> Sharp reversal hitting lower circuit at ₹310.55 (-4.94%)</p>\n <p><strong>Jan 22:</strong> Continued decline to ₹290.10 (-3.20%)</p>\n <p><strong>Jan 23:</strong> Week closes at ₹282.15 (-2.74%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.310.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.282.15</div><div class=\"stat-chang..." }, { "title": "Nureca Ltd Hits Lower Circuit Amid Heavy Selling Pressure and Panic Selling", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-hits-lower-circuit-amid-heavy-selling-pressure-and-panic-selling-3795745", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_stocks_hitting_lower_circuit_3795745.png", "date": "2026-01-20 10:00:22", "description": "Shares of Nureca Ltd, a micro-cap player in the Healthcare Services sector, plunged sharply on 20 Jan 2026, hitting the lower circuit limit amid intense selling pressure. The stock recorded its maximum daily loss in recent months, reflecting a sudden shift in investor sentiment and panic selling that overwhelmed available supply." }, { "title": "Nureca Ltd Surges to Upper Circuit Amid Robust Buying Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-surges-to-upper-circuit-amid-robust-buying-pressure-3794315", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_stocks_hitting_upper_circuit_3794315.png", "date": "2026-01-19 10:00:25", "description": "Nureca Ltd, a micro-cap player in the healthcare services sector, surged to hit its upper circuit limit on 19 Jan 2026, propelled by robust buying interest and sustained investor enthusiasm. The stock closed at ₹322.05, marking a maximum daily gain of 3.27%, outperforming its sector and broader market indices amid heightened liquidity and demand." }, { "title": "Nureca Ltd Upgraded to Hold by MarketsMOJO on Improving Technicals and Financials", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-upgraded-to-hold-by-marketsmojo-on-improving-technicals-and-financials-3793847", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_mojoScore_3793847.png", "date": "2026-01-19 08:11:09", "description": "Nureca Ltd, a player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 17 January 2026. This change reflects a combination of improved technical indicators, steady financial results, and a more balanced valuation outlook despite lingering concerns over long-term fundamentals and profitability. The stock’s recent price action and quarterly performance have prompted analysts to reassess its prospects amid a challenging industry backdrop." }, { "title": "Why is Nureca Ltd falling/rising?", "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-nureca-ltd-fallingrising-3793219", "imagepath": "", "date": "2026-01-17 01:00:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Momentum and Market Outperformance</strong></p>\n<p>The stock has demonstrated significant upward momentum over the past week, delivering a 9.95% gain compared to a flat Sensex performance. Over the last month, Nureca outpaced the benchmark by a wide margin, rising 13.57% while the Sensex declined by 1.31%. Year-to-date, the stock has managed a modest 1.07% increase, again outperforming the Sensex’s 1.94% decline. This recent rally is further underscored by a three-day consecutive gain period, during which the stock appreciated by 11.79%, signalling sustained buying interest.</p>\n<p>Intraday trading on 16-Jan saw the stock touch a high of Rs 310.95, marking a 5% increase from the previous close, despite an intraday low of Rs 288.6. Notably, Nureca is trading above all key moving ..." }, { "title": "Nureca Ltd Upgraded to Hold as Technicals and Financials Show Mixed Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-upgraded-to-hold-as-technicals-and-financials-show-mixed-signals-3782771", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/NurecaLtd_mojoScore_3782771.png", "date": "2026-01-06 08:52:26", "description": "Nureca Ltd, a player in the Healthcare Services sector, has seen its investment rating upgraded from Sell to Hold as of 5 January 2026. This change reflects a combination of improved technical indicators, robust recent financial results, and rising promoter confidence, despite lingering concerns over long-term fundamentals and valuation risks." }, { "title": "Nureca Ltd Gains 6.05%: 2 Key Events Shaping the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-gains-605-2-key-events-shaping-the-week-3779512", "imagepath": "", "date": "2026-01-03 11:39:00", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>29 Dec 2025:</strong> Downgrade to Sell by MarketsMOJO</p>\n <p><strong>31 Dec 2025:</strong> Stock hits upper circuit limit at Rs.307.95</p>\n <p><strong>2 Jan 2026:</strong> Week closes at Rs.302.50 (+6.05%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.285.25</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.302.50</div><div class=\"stat-change positive\">+6.05%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week ..." }, { "title": "Nureca Ltd Surges to Upper Circuit on Strong Buying Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/nureca-ltd-surges-to-upper-circuit-on-strong-buying-momentum-3776074", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NurecaLtd_stocks_hitting_upper_circuit_3776074.png", "date": "2025-12-31 10:00:24", "description": "Nureca Ltd, a micro-cap player in the Healthcare Services sector, surged to hit its upper circuit price limit on 31 Dec 2025, reflecting strong investor demand and positive market sentiment. The stock closed at ₹307.95, marking a maximum daily gain of 4.99%, significantly outperforming its sector and broader market benchmarks." }, { "title": "Nureca Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/nureca-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3774481", "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/NurecaLtd_mojoScore_3774481.png", "date": "2025-12-30 08:58:45", "description": "Nureca Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 29 Dec 2025. This shift reflects a complex interplay of factors including deteriorating long-term fundamentals, mixed technical indicators, and valuation concerns despite recent positive quarterly financial results and rising promoter confidence." } ], "total": 245, "sid": "1003462", "stock_news_url": "https://www.marketsmojo.com/news/nureca-1003462" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "20-Jan-2026", "details": "Nureca Limited has informed the Exchange regarding Newspaper Publication.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "19-Jan-2026", "details": "Nureca Limited has informed the exchange regarding Newspaper Publication.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation", "datetime": "18-Jan-2026", "details": "Nureca limited has informed the exchange regarding Investor Presentation.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Nureca Ltd has declared <strong>30%</strong> dividend, ex-date: 24 Feb 22", "dt": "2022-02-24", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Jan 19: Stock surged to upper circuit at ₹322.05 (+5.0%)

Jan 20: Sharp reversal hitting lower circuit at ₹310.55 (-4.94%)

Jan 22: Continued decline to ₹290.10 (-3.20%)

Jan 23: Week closes at ₹282.15 (-2.74%)

Read full news article

Nureca Ltd Hits Lower Circuit Amid Heavy Selling Pressure and Panic Selling

2026-01-20 10:00:22

Shares of Nureca Ltd, a micro-cap player in the Healthcare Services sector, plunged sharply on 20 Jan 2026, hitting the lower circuit limit amid intense selling pressure. The stock recorded its maximum daily loss in recent months, reflecting a sudden shift in investor sentiment and panic selling that overwhelmed available supply.

Read full news article

Nureca Ltd Surges to Upper Circuit Amid Robust Buying Pressure

2026-01-19 10:00:25

Nureca Ltd, a micro-cap player in the healthcare services sector, surged to hit its upper circuit limit on 19 Jan 2026, propelled by robust buying interest and sustained investor enthusiasm. The stock closed at ₹322.05, marking a maximum daily gain of 3.27%, outperforming its sector and broader market indices amid heightened liquidity and demand.

Read full news article

Nureca Ltd Upgraded to Hold by MarketsMOJO on Improving Technicals and Financials

2026-01-19 08:11:09

Nureca Ltd, a player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold as of 17 January 2026. This change reflects a combination of improved technical indicators, steady financial results, and a more balanced valuation outlook despite lingering concerns over long-term fundamentals and profitability. The stock’s recent price action and quarterly performance have prompted analysts to reassess its prospects amid a challenging industry backdrop.

Read full news article

Why is Nureca Ltd falling/rising?

2026-01-17 01:00:03

Recent Price Momentum and Market Outperformance

The stock has demonstrated significant upward momentum over the past week, delivering a 9.95% gain compared to a flat Sensex performance. Over the last month, Nureca outpaced the benchmark by a wide margin, rising 13.57% while the Sensex declined by 1.31%. Year-to-date, the stock has managed a modest 1.07% increase, again outperforming the Sensex’s 1.94% decline. This recent rally is further underscored by a three-day consecutive gain period, during which the stock appreciated by 11.79%, signalling sustained buying interest.

Intraday trading on 16-Jan saw the stock touch a high of Rs 310.95, marking a 5% increase from the previous close, despite an intraday low of Rs 288.6. Notably, Nureca is trading above all key moving ...

Read full news article

Nureca Ltd Upgraded to Hold as Technicals and Financials Show Mixed Signals

2026-01-06 08:52:26

Nureca Ltd, a player in the Healthcare Services sector, has seen its investment rating upgraded from Sell to Hold as of 5 January 2026. This change reflects a combination of improved technical indicators, robust recent financial results, and rising promoter confidence, despite lingering concerns over long-term fundamentals and valuation risks.

Read full news article

Nureca Ltd Gains 6.05%: 2 Key Events Shaping the Week

2026-01-03 11:39:00

Key Events This Week

29 Dec 2025: Downgrade to Sell by MarketsMOJO

31 Dec 2025: Stock hits upper circuit limit at Rs.307.95

2 Jan 2026: Week closes at Rs.302.50 (+6.05%)

Read full news article

Nureca Ltd Surges to Upper Circuit on Strong Buying Momentum

2025-12-31 10:00:24

Nureca Ltd, a micro-cap player in the Healthcare Services sector, surged to hit its upper circuit price limit on 31 Dec 2025, reflecting strong investor demand and positive market sentiment. The stock closed at ₹307.95, marking a maximum daily gain of 4.99%, significantly outperforming its sector and broader market benchmarks.

Read full news article

Nureca Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2025-12-30 08:58:45

Nureca Ltd, a player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 29 Dec 2025. This shift reflects a complex interplay of factors including deteriorating long-term fundamentals, mixed technical indicators, and valuation concerns despite recent positive quarterly financial results and rising promoter confidence.

Read full news article

View All News